Cellsenescence,whenstressedcellscanno longer divide to make new cells, is considered a factorinagingandinsomediseases. As your body ages,increasingamountsofcellsenterinto a stateofsenescence.
Senolyticdrugs as anti-agingdrugs are a promisingapproach to removesenescentcells, but researchersarestill trying to figure outtheroleofcellularsenescenceanddifferent ways to approach it.
Researchers attheUniversityofCalifornia,SanFrancisco(UCSF),report they havediscoveredhowimmunecellsnaturallyclearthebodyofsenescentcells. Their newfindings in mice may lead to new strategiesandapproaches to treating age-related chronic diseases withimmunotherapy.
The accumulationofsenescentcellswithintissuescan drive the progressionofdiseases,wrote the researchers.
While removalofsenescentcells with senolytic drugs hasemerged as a promisingtherapeuticapproach,theubiquitoustargetof these drugs makesclinicalapplicationschallenging.
Immune cellsknown as invariantNaturalKiller T (iNKT)cellsfunction as a surveillancesystem,eliminatingcellssuch as senescentcells.However,iNKTcellsbecome less activewith age andfactorsthatcontribute to chronicdisease.
The researchersstartedtoinvestigatedifferentways to stimulatethisnaturalsurveillancesystemthatoffers an alternative tosenolyticdrugs.
The scientistsdiscovered they couldremovesenescentcells by usinglipidantigensto activate iNKTcells.Researchersobservedimprovementsin mice withdiet-induced obesity. Theirbloodglucoselevelsimproved, and mice withlungfibrosishadfewer damaged cells.
The resultsprovidethefirstevidencethatiNKTcellscaneliminatesenescentcellsinthese two distinctmodelswheretissuedysfunctionisdependentontheaccumulationofsenescentcells.